Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Westermark
Giampaolo Merlini

Showing results (401-410 of 587) with videos related to

Pageof 59
Sort By:
Human Mutation|July 22, 2014
Online registry for mutations in hereditary amyloidosis including nomenclature recommendationsDorota M Rowczenio, Islam Noor, Julian D Gillmore, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 12, 2010
Embryonic stem and haematopoietic progenitor cells resist to Aβ oligomer toxicity and maintain the differentiation potency in cultureTui Neri, Monica Bucciantini, Vittorio Rosti, et al.
American Journal of Hematology|April 14, 2020
High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltratePaolo Milani, Francesca Fazio, Marco Basset, et al.
Seminars in Hematology|April 26, 2023
Report of Consensus Panel 6 from the 11 th International Workshop on Waldenström's Macroglobulinemia on Management of Waldenström's Macroglobulinemia Related AmyloidosisGiampaolo Merlini, Shayna Sarosiek, Giulia Benevolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2016
European Collaborative Study Defining Clinical Profile Outcomes and Novel Prognostic Criteria in Monoclonal Immunoglobulin M-Related Light Chain AmyloidosisSajitha Sachchithanantham, Murielle Roussel, Giovanni Palladini, et al.
Molecular Biosystems|November 26, 2010
Beta2-microglobulin causes abnormal phosphatidylserine exposure in human red blood cellsBarbara Pavone, Sonia Bucci, Vittorio Sirolli, et al.
The Journal of Biological Chemistry|September 21, 2020
Mass spectrometry characterization of light chain fragmentation sites in cardiac AL amyloidosis: insights into the timing of proteolysisFrancesca Lavatelli, Giulia Mazzini, Stefano Ricagno, et al.
Molecular & Cellular Proteomics : MCP|May 14, 2008
Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissueFrancesca Lavatelli, David H Perlman, Brian Spencer, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 16, 2019
Zebrafish model of amyloid light chain cardiotoxicity: regeneration versus degenerationShikha Mishra, Shaurya Joshi, Jennifer E Ward, et al.
Scientific Reports|June 11, 2016
Corrigendum: Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidosesNatalie J Galant, Antoinette Bugyei-Twum, Rishi Rakhit, et al.
Pageof 59

Showing results (401-410 of 587) with videos related to

Sort By:
Pageof 59
Human Mutation|July 22, 2014
Online registry for mutations in hereditary amyloidosis including nomenclature recommendationsDorota M Rowczenio, Islam Noor, Julian D Gillmore, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 12, 2010
Embryonic stem and haematopoietic progenitor cells resist to Aβ oligomer toxicity and maintain the differentiation potency in cultureTui Neri, Monica Bucciantini, Vittorio Rosti, et al.
American Journal of Hematology|April 14, 2020
High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltratePaolo Milani, Francesca Fazio, Marco Basset, et al.
Seminars in Hematology|April 26, 2023
Report of Consensus Panel 6 from the 11 th International Workshop on Waldenström's Macroglobulinemia on Management of Waldenström's Macroglobulinemia Related AmyloidosisGiampaolo Merlini, Shayna Sarosiek, Giulia Benevolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2016
European Collaborative Study Defining Clinical Profile Outcomes and Novel Prognostic Criteria in Monoclonal Immunoglobulin M-Related Light Chain AmyloidosisSajitha Sachchithanantham, Murielle Roussel, Giovanni Palladini, et al.
Molecular Biosystems|November 26, 2010
Beta2-microglobulin causes abnormal phosphatidylserine exposure in human red blood cellsBarbara Pavone, Sonia Bucci, Vittorio Sirolli, et al.
The Journal of Biological Chemistry|September 21, 2020
Mass spectrometry characterization of light chain fragmentation sites in cardiac AL amyloidosis: insights into the timing of proteolysisFrancesca Lavatelli, Giulia Mazzini, Stefano Ricagno, et al.
Molecular & Cellular Proteomics : MCP|May 14, 2008
Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissueFrancesca Lavatelli, David H Perlman, Brian Spencer, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 16, 2019
Zebrafish model of amyloid light chain cardiotoxicity: regeneration versus degenerationShikha Mishra, Shaurya Joshi, Jennifer E Ward, et al.
Scientific Reports|June 11, 2016
Corrigendum: Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidosesNatalie J Galant, Antoinette Bugyei-Twum, Rishi Rakhit, et al.
Pageof 59